177 related articles for article (PubMed ID: 29666360)
1. Signaling pathways responsible for the rapid antidepressant-like effects of a GluN2A-preferring NMDA receptor antagonist.
Gordillo-Salas M; Pilar-Cuéllar F; Auberson YP; Adell A
Transl Psychiatry; 2018 Apr; 8(1):84. PubMed ID: 29666360
[TBL] [Abstract][Full Text] [Related]
2. Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc.
Szewczyk B; Pochwat B; Rafało A; Palucha-Poniewiera A; Domin H; Nowak G
Neuropharmacology; 2015 Dec; 99():517-26. PubMed ID: 26297535
[TBL] [Abstract][Full Text] [Related]
3. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
[TBL] [Abstract][Full Text] [Related]
4. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
[TBL] [Abstract][Full Text] [Related]
5. Cortical and raphe GABA
Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
[TBL] [Abstract][Full Text] [Related]
6. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
[TBL] [Abstract][Full Text] [Related]
7. The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT
Sayson LV; Botanas CJ; Custodio RJP; Abiero A; Kim M; Lee HJ; Kim HJ; Yoo SY; Lee KW; Ryu HW; Acharya S; Kim KM; Lee YS; Cheong JH
Psychopharmacology (Berl); 2019 Jul; 236(7):2201-2210. PubMed ID: 30891619
[TBL] [Abstract][Full Text] [Related]
8. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
Pałucha-Poniewiera A; Szewczyk B; Pilc A
Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying the rapid-acting antidepressant-like effects of neuropeptide VGF (non-acronymic) C-terminal peptide TLQP-62.
Lv D; Chen Y; Shen M; Liu X; Zhang Y; Xu J; Wang C
Neuropharmacology; 2018 Dec; 143():317-326. PubMed ID: 30291938
[TBL] [Abstract][Full Text] [Related]
10. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
[TBL] [Abstract][Full Text] [Related]
11. Acute Amino Acid d-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms.
Wei IH; Chen KT; Tsai MH; Wu CH; Lane HY; Huang CC
J Agric Food Chem; 2017 Dec; 65(49):10792-10803. PubMed ID: 29161812
[TBL] [Abstract][Full Text] [Related]
12. TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.
Suzuki A; Murakami K; Tajima Y; Hara H; Kunugi A; Kimura H
Pharmacol Biochem Behav; 2019 Aug; 183():80-86. PubMed ID: 31202810
[TBL] [Abstract][Full Text] [Related]
13. NMDA GluN2B receptors involved in the antidepressant effects of curcumin in the forced swim test.
Zhang L; Xu T; Wang S; Yu L; Liu D; Zhan R; Yu SY
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():12-7. PubMed ID: 22960607
[TBL] [Abstract][Full Text] [Related]
14. Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responses.
Voleti B; Navarria A; Liu RJ; Banasr M; Li N; Terwilliger R; Sanacora G; Eid T; Aghajanian G; Duman RS
Biol Psychiatry; 2013 Nov; 74(10):742-9. PubMed ID: 23751205
[TBL] [Abstract][Full Text] [Related]
15. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR.
Akinfiresoye L; Tizabi Y
Psychopharmacology (Berl); 2013 Nov; 230(2):291-8. PubMed ID: 23732839
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effects induced by NMDA receptor blockade and NO synthesis inhibition in the ventral medial prefrontal cortex of rats exposed to the forced swim test.
Pereira VS; Romano A; Wegener G; Joca SR
Psychopharmacology (Berl); 2015 Jul; 232(13):2263-73. PubMed ID: 25589143
[TBL] [Abstract][Full Text] [Related]
18. The role of GluN2A and GluN2B subunits on the effects of NMDA receptor antagonists in modeling schizophrenia and treating refractory depression.
Jiménez-Sánchez L; Campa L; Auberson YP; Adell A
Neuropsychopharmacology; 2014 Oct; 39(11):2673-80. PubMed ID: 24871546
[TBL] [Abstract][Full Text] [Related]
19. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism.
Kiselycznyk C; Jury NJ; Halladay LR; Nakazawa K; Mishina M; Sprengel R; Grant SG; Svenningsson P; Holmes A
Behav Brain Res; 2015; 287():89-95. PubMed ID: 25800971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
